Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
Poster available until
  • Until platform closure (4)
Poster categories
  • Thematic Poster Session (4)
keywords
Session Reference
  • L-TPS01 (12)
  • L-TPS02 (14)
  • L-TPS03 (10)
  • L-TPS04 (13)
  • L-TPS05 (10)
  • L-TPS06 (8)
  • L-TPS07 (14)
  • L-TPS08 (9)
  • L-TPS09 (13)
  • L-TPS10 (14)
  • L-TPS11 (15)
  • L-TPS12 (11)
  • L-TPS13 (12)
  • L-TPS14 (14)
  • L-TPS15 (12)
  • L-TPS16 (9)
  • L-TPS17 (13)
  • L-TPS18 (13)
  • L-TPS19 (9)
  • L-TPS20 (14)
  • L-TPS21 (8)
  • L-TPS22 (10)
  • L-TPS23 (14)
  • L-TPS24 (14)
  • L-TPS25 (5)
  • TPS01 (14)
  • TPS02 (12)
  • TPS03 (10)
  • TPS04 (12)
  • TPS05 (13)
  • TPS06 (14)
  • TPS07 (9)
  • TPS08 (15)
  • TPS09 (14)
  • TPS10 (11)
  • TPS11 (13)
  • TPS12 (12)
  • TPS13 (11)
  • TPS14 (12)
  • TPS15 (9)
  • TPS16 (12)
  • TPS17 (12)
  • TPS18 (11)
  • TPS19 (11)
  • TPS20 (13)
  • TPS21 (14)
  • TPS22 (11)
  • TPS23 (11)
  • TPS24 (12)
  • TPS25 (8)
  • TPS26 (16)
  • TPS27 (13)
  • TPS28 (5)
  • TPS29 (6)
  • TPS30 (12)
  • TPS31 (10)
  • TPS32 (12)
  • TPS33 (14)
  • TPS34 (15)
  • TPS35 (11)
  • TPS36 (11)
  • TPS37 (12)
  • TPS38 (12)
  • TPS39 (13)
  • TPS40 (10)
  • TPS41 (14)
  • TPS42 (15)
  • TPS43 (15)
  • TPS44 (14)
  • TPS45 (12)
  • TPS46 (11)
  • TPS47 (14)
  • TPS48 (11)
  • TPS49 (12)
  • TPS50 (9)
  • TPS51 (8)
  • TPS52 (14)
  • TPS53 (12)
  • TPS54 (11)
  • TPS55 (13)
  • TPS56 (13)
  • TPS57 (5)
  • TPS58 (4)
  • TPS59 (12)
  • TPS60 (12)
  • TPS61 (12)
  • TPS62 (13)
  • TPS63 (12)
  • TPS64 (15)
  • TPS65 (14)
  • TPS66 (13)
  • TPS67 (13)
  • TPS68 (11)
  • TPS69 (15)
  • TPS70 (13)
  • TPS71 (9)
  • TPS72 (13)
  • TPS73 (12)
  • TPS74 (10)
  • TPS75 (13)
  • TPS76 (10)
  • TPS77 (7)
  • TPS78 (14)
  • TPS79 (13)
  • TPS80 (11)
  • TPS81 (6)
  • TPS82 (12)
  • TPS83 (6)
  • TPS84 (11)
  • TPS85 (11)
  • TPS86 (13)
  • TPS87 (10)
  • x TPS88 (9)
  • x TPS89 (7)
  • x TPS90 (5)
  • TPS91 (5)
21 results
Thumbnail

- D3.519 - Post-COVID-19 Reshaping of Molecular IgE Sensitization Profiles to Seasonal and Indoor Allergens

Thumbnail

- D3.520 - Post-COVID Olfactory and Taste Dysfunction in Students at a South African Medical School

Thumbnail

D3.521 - Dermatologic adverse effects of COVID-19 vaccination

Thumbnail

- D3.522 - Post-Vaccination SARS-CoV-2 Infections: Evidence, Severity, and Outcomes

Thumbnail

D3.523 - Early childhood: a risk predictor for post-COVID-19 pulmonary sequelae in children

Thumbnail

- D3.524 - Clinical use of procalcitonin and IL-6 in diagnosis of bacterial superinfection in COVID-19

Thumbnail

- D3.525 - One- year hospital readmission after pediatric COVID- 19 hospitalization: a single- center cohort study

Thumbnail

- D3.526 - Baseline demographic characteristics and early-life exposures in infants born during and after the COVID-19 pandemic: A comparison of the CORAL and FLORAL birth cohorts

Thumbnail

- D3.527 - Multisystem Inflammatory Syndrome in Children (MIS-C) as a Condition Resulting from Immune Dysregulation: What has Coronavirus Infection Taught Us? (Case Study)

Thumbnail

D3.529 - Altered Virulence of Pseudomonas aeruginosa from Polystyrene-Fed Zophobas atratus Larvae and Immunological Effects of Microplastics on Murine Lungs

Thumbnail

- D3.530 - Nonresponsiveness to Hepatitis B Vaccine Is Characterized by Reduced T Stem Cell Memory (TSCM) Cells

Thumbnail

- D3.531 - Diverse Infectious Disease Outcomes After SARS CoV 2 Infection in Children and Adolescents: A Nationwide Matched Cohort Study

Thumbnail

- D3.536 - Staphylococcus aureus bacteria as a causative agent of upper respiratory tract allergies

Thumbnail

- D3.532 - Influence of sensitization on persistent symptoms of chronic fatigue

Thumbnail

D3.533 - Prevalence of dysplasia and cervical cancer of papillomavirus origin in women of different age groups

Thumbnail

- D3.537 - Immunologic and other factors influencing clearance of viral hepatitis infections

Thumbnail

- D3.540 - Sources of IL-13 in Acute Versus Chronic Models of Eosinophilic Esophagitis

Thumbnail

- D3.538 - Aeroallergen sensitisation as a risk factor for paediatric eosinophilic esophagitis

Thumbnail

- D3.539 - Evaluation of Treatment Selection and Response in Patients with Eosinophilic Esophagitis Based on Clinical Findings and Allergy Testing

Thumbnail

- D3.541 - Who takes the patient with eosinophilic esophagitis (EoE) and acute laryngeal edema?

Pagination

  • Current page 1
  • Page 2
  • Next page Next
  • Last page Last
Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2026 EAACI
Made with   by CYIM